TAZVERIK® (tazemetostat) is a prescription medicine for adults with relapsed or refractory follicular lymphoma or advanced epithelioid sarcoma. See Important Safety Information and …

TAZVERIK® (tazemetostat) is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma. Review efficacy and safety data, dosing, or contact a rep. See …

TAZVERIK® (tazemetostat) is a prescription oral medicine for adults 16+ with advanced epithelioid sarcoma. Find patient resources, study results, side effects, and how to take …

TAZVERIK® (tazemetostat) is indicated for the treatment of adult patients with advanced epithelioid sarcoma. Review efficacy and safety data, dosing, or contact a rep. See Important …

TAZVERIK® (tazemetostat) inhibits EZH2 activity and may reduce B-cell proliferation associated with follicular lymphoma. TAZVERIK can cause serious side effects, including risk of new …

How TAZVERIK® (tazemetostat) works differently from other cancer treatments. TAZVERIK can cause serious side effects, including risk of new cancers and an increase in new (second) …

TAZVERIK is a prescription medicine used to treat: Adults with follicular lymphoma when the disease has come back or did not respond to treatment, whose tumors have an abnormal …

TAZVERIK is FDA approved to treat relapsed or refractory follicular lymphoma. See Important Safety Information and full Prescribing Information, including Medication Guide. How …

Recommended dosing for TAZVERIK® (tazemetostat), an oral, twice-daily tablet for patients with relapsed or refractory follicular lymphoma. Avoid coadministration of strong or moderate …

TAZVERIK® (tazemetostat) is a prescription oral medicine for adults with relapsed or refractory follicular lymphoma. Find patient resources, study results, side effects, and how to take …